Nektar Therapeutics | Interessi Passivi Sul Debito



Interest Expense On Debt Cambiamento Data
Agios Pharmaceuticals 3.01M 10.05M 2024-12
ALKERMES USD 0 4.65M 2025-03
Amgen USD 723M 24M 2025-03
Baxter International USD 100M 1000K 2024-12
Biogen USD 60M 200K 2024-12
Bristol-Myers Squibb USD 494M 2M 2025-03
Cipla 140.2M 6.2M 2025-03
Dr.Reddys Laboratories 656M 162M 2025-03
Eisai 1.09B 313M 2025-03
Eli Lilly USD 243.7M 19M 2025-03
Exelixis 23.4M 3.9M 2023-09
Gilead Sciences USD 260M 12M 2025-03
GlaxoSmithKline 162M 11M 2025-03
Grifols EUR 197.61M 13.11M 2024-09
Halozyme Therapeutics USD 4.52M 15K 2025-03
Incyte USD 660K 241K 2025-03
Ionis Pharmaceuticals USD 19M 16.41M 2025-03
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
MacroGenics USD -24000 24K 2024-12
Merck USD 313M 15M 2025-03
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 275M 11M 2024-12
Pfizer USD 654M 85M 2025-03
Roche Holding CHF 311.5M 1000K 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
Takeda 50.32B 18.73B 2025-03
Teva Pharmaceutical Industries USD 212M 12M 2025-03
Xencor 8.66M 48.02M 2025-03



Nektar Therapeutics Interessi Passivi Sul Debito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.